Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $924,912. The enterprise value is -$14.71 million.
| Market Cap | 924,912 |
| Enterprise Value | -14.71M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 994,529 shares outstanding. The number of shares has increased by 60.28% in one year.
| Shares Outstanding | 994,529 |
| Shares Change (YoY) | +60.28% |
| Shares Change (QoQ) | -7.33% |
| Owned by Insiders (%) | 9.45% |
| Owned by Institutions (%) | 6.51% |
| Float | 953,395 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | 0.02 |
| PB Ratio | 0.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.48 |
| Quick Ratio | 3.39 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.94 |
Financial Efficiency
Return on equity (ROE) is -21.00% and return on invested capital (ROIC) is -21.89%.
| Return on Equity (ROE) | -21.00% |
| Return on Assets (ROA) | -16.30% |
| Return on Capital (ROIC) | -21.89% |
| Revenue Per Employee | $547,563 |
| Profits Per Employee | -$102,410 |
| Employee Count | 44 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 3.49 |
Taxes
In the past 12 months, SBFM has paid $395,166 in taxes.
| Income Tax | 395,166 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.61% in the last 52 weeks. The beta is -1.11, so SBFM's price volatility has been lower than the market average.
| Beta (1Y) | -1.11 |
| 52-Week Price Change | -98.61% |
| 50-Day Moving Average | 6.14 |
| 200-Day Moving Average | 26.87 |
| Relative Strength Index (RSI) | 29.54 |
| Average Volume (30 Days) | 735,437 |
Short Selling Information
The latest short interest is 706,696, so 71.06% of the outstanding shares have been sold short.
| Short Interest | 706,696 |
| Short Previous Month | 970,972 |
| Short % of Shares Out | 71.06% |
| Short % of Float | 74.12% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, SBFM had revenue of $24.09 million and -$4.51 million in losses. Loss per share was -$19.00.
| Revenue | 24.09M |
| Gross Profit | 8.34M |
| Operating Income | -4.79M |
| Pretax Income | -4.11M |
| Net Income | -4.51M |
| EBITDA | -3.82M |
| EBIT | -3.97M |
| Loss Per Share | -$19.00 |
Balance Sheet
The company has $16.29 million in cash and $657,705 in debt, giving a net cash position of $15.63 million or $15.72 per share.
| Cash & Cash Equivalents | 16.29M |
| Total Debt | 657,705 |
| Net Cash | 15.63M |
| Net Cash Per Share | $15.72 |
| Equity / Book Value | 21.21M |
| Book Value Per Share | 21.32 |
| Working Capital | 19.34M |
Cash Flow
In the last 12 months, operating cash flow was -$8.78 million and capital expenditures $49,698, giving a free cash flow of -$8.73 million.
| Operating Cash Flow | -8.78M |
| Capital Expenditures | 49,698 |
| Free Cash Flow | -8.73M |
| FCF Per Share | -$35.86 |
Margins
Gross margin is 34.61%, with operating and profit margins of -19.86% and -18.70%.
| Gross Margin | 34.61% |
| Operating Margin | -19.86% |
| Pretax Margin | -17.06% |
| Profit Margin | -18.70% |
| EBITDA Margin | -15.87% |
| EBIT Margin | -16.49% |
| FCF Margin | -36.22% |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.28% |
| Shareholder Yield | -60.28% |
| Earnings Yield | -487.19% |
| FCF Yield | -943.38% |
Analyst Forecast
The average price target for SBFM is $260.00, which is 27,856.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $260.00 |
| Price Target Difference | 27,856.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 17, 2024. It was a reverse split with a ratio of 1:100.
| Last Split Date | Apr 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
SBFM has an Altman Z-Score of -1.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.93 |
| Piotroski F-Score | 3 |